Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

Jiaying This is The English We Speak from BBC Learning English and we’re talking about the phrase ‘another string to your bow’ which describes having an additional skill to use if the first skill ...

Sports News, Scores, Fantasy Games As NBA observers, we must always have an eye toward the future in an attempt to identify the next big thing. Here are three players we at least should keep under a ...